Document is current

Article History

Received: 24 March 2025

Accepted: 23 May 2025

First Online: 28 June 2025

Declarations

:

: David Tabano and Ayesha Ahmed are employees of Genentech, Inc. Oliver Cox is an employee of F. Hoffmann-La Roche Ltd. Sarah R. Hill, Louise Longworth, and Yemi Oluboyede received funding from F. Hoffmann-La Roche Ltd. to conduct the research presented in this manuscript. Nimesh A. Patel is an advisor for Alcon, Allergan Dorc, Alimera, Eye Point, and Genentech. Richard Gale is a consultant for Abbvie, Apellis, Bayer, Biogen, Boehringer Ingelhiem, Novartis, and Roche. Arjun Watane has no financial disclosures to declare. Since the completion of this manuscript, Louise Longworth has changed affiliations and is now affiliated with Arrow Health Economics.

: These study materials were ethically reviewed by an independent research ethics expert under the auspices of the Association of Research Managers and Administrators (ARMA), who provided a “favorable ethics opinion” for the study. This study involved data collection from participants across multiple countries; however, all data were collected online via recruitment from a central patient panel, and no collaborative institutions were involved in this study to necessitate institution-specific ethical approval. All participants provided informed consent to participate in the study prior to completing the survey. The study did not collect identifiable personal information; therefore, specific consent for publication of identifiable data was not applicable. However, participants consented to the publication of the anonymized study results for research purposes. The study was conducted in accordance with the ethical principles set forth in the Declaration of Helsinki (1964) and its later amendments.